skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Allogeneic Large Multivalent Immunogen Breast Cancer Vaccine (Code C79799)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Allogeneic Large Multivalent Immunogen Breast Cancer Vaccine

Definition: A cancer vaccine, containing human-specific large multivalent immunogens (LMIs) isolated from the membrane fraction of cells from a breast cancer cell line, with potential immunostimulatory and antineoplastic activities. Upon administration, allogeneic large multivalent immunogen breast cancer vaccine may stimulate a cytotoxic T lymphocyte (CTL) immune response against tumor cells that express the breast cancer cell-specific LMIs.

Display Name: Allogeneic Large Multivalent Immunogen Breast Cancer Vaccine

Label: Allogeneic Large Multivalent Immunogen Breast Cancer Vaccine

NCI Thesaurus Code: C79799 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL388414  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Allogeneic Large Multivalent Immunogen Breast Cancer Vaccine
Allogeneic LMI Breast Cancer Vaccine

External Source Codes: 
PDQ Closed Trial Search ID 619122
PDQ Open Trial Search ID 619122 (check for NCI PDQ open clinical trial info)
NCI META CUI CL388414

Other Properties:
     Name Value (qualifiers indented underneath)
code C79799
Contributing_Source CTRP
Legacy_Concept_Name Allogeneic_Large_Multivalent_Immunogen_Breast_Cancer_Vaccine
Semantic_Type Immunologic Factor
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  

URL: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C79799

Mainbox Bottom